Mechanisms in endocrinology: gut microbiota in patients with type 2 diabetes mellitus
If you are a GLP-1 user If you are coming to the end of GLP-1 treatment, reducing medication, stopping treatment or trying to maintain weight loss after Ozempic, Wegovy or Mounjaro, The GLP-1 Legacy was written for this phase
PGC: OR = 0.71, 95% CI [0.580.87]
Confirmed for 2026 Medicare GLP-1 Bridge Program July 1, 2026 The Medicare GLP-1 Bridge program launches July 1, 2026 , covering Zepbound KwikPen for obesity for the first time
This webinar is part of IIN's newly updated 2026 Health Coach Training Program curriculum, which now includes expert lectures on supporting clients through modern weight loss approaches including GLP-1 medications, AI-assisted health coaching, and oral-systemic health connections." Supporting Clients Who Do Use GLP-1s: An Integrated Approach When clients are on GLP-1 medications, coaching doesnt disappearit adapts
It is a master regulator of appetite, metabolism, and glucose control